Andrew Hendifar
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute · Cedars-Sinai Medical Center · Cedars-Sinai
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrew Hendifar as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:35 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05766748 · Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic CancerCantex Pharmaceuticals · unknown · Metastatic Pancreatic Cancer · principal investigator
- Early Ph1NCT05336266 · A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal AdenocarcinomaAndrew Hendifar, MD · active not recruiting · Pancreas Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer · principal investigator
- N/ANCT05078775 · Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic CancerFaeth Therapeutics · completed · Metastatic Pancreatic Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma · principal investigator
- Ph2NCT04798781 · Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular CarcinomaAndrew Hendifar, MD · completed · Gastric Cancer, Hepatocellular Carcinoma · principal investigator
- Ph2NCT04098237 · Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic InsufficiencyAndrew Hendifar, MD · active not recruiting · Pancreatic Adenocarcinoma · principal investigator
- N/ANCT04034745 · Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/GainAndrew Hendifar, MD · withdrawn · Pancreatic Cancer, Neuroendocrine Tumors, Cachexia; Cancer · principal investigator
- Ph1NCT03207724 · Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With CachexiaAndrew Hendifar, MD · completed · Pancreatic Cancer, Cachexia, Weight Loss · principal investigator
- N/ANCT02400398 · Evaluating Weight Stability of Pancreatic Cancer Cachexia PatientsAndrew Hendifar, MD · completed · Pancreatic Neoplasms, Pancreatic Cancer, Cachexia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:35 UTC. The ranking covers the 200 most relevant of 27 PubMed records, and a shared surname and initials can bring in a namesake. All 27 on PubMed
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.N Engl J Med · 20172,659 citationsRCR 108.7
- 532 citationsRCR 36.4
- Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.J Clin Oncol · 2020451 citationsRCR 18.9
- 419 citationsRCR 14.4
- Ponsegromab for the Treatment of Cancer Cachexia.N Engl J Med · 2024302 citationsRCR 45.5
- Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial.J Clin Oncol · 2018297 citationsRCR 13.2
- Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).J Clin Oncol · 2023290 citationsRCR 36.6
- 148 citationsRCR 4.0
- Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.J Clin Oncol · 2014130 citationsRCR 3.6
- 106 citationsRCR 5.1